Larsen, Brianna and Cox, Amanda and Colbey, Candice and Drew, Michael and McGuire, Helen and Fazekas de St Groth, Barbara and Hughes, David and Vlahovich, Nicole and Waddington, Gordon and Burke, Louise and Lundy, Bronwen and West, Nicholas and Minahan, Clare (2020) Inflammation and Oral Contraceptive Use in Female Athletes Before the Rio Olympic Games. Frontiers in Physiology, 11:497. pp. 1-8.
|
Text (Published Version)
Larsen et al 2020_Rio paper.pdf Available under License Creative Commons Attribution 4.0. Download (1MB) | Preview |
Abstract
This study investigated the association between synthetic ovarian hormone use [i.e., the oral contraceptive (OC) pill] and basal C-reactive protein (CRP), peripheral blood immune cell subsets, and circulating pro- and anti-inflammatory cytokine concentrations in elite female athletes. Elite female athletes (n = 53) selected in Rio Summer Olympic squads participated in this study; 25 were taking an OC (AthletesOC) and 28 were naturally hormonally cycling (AthletesNC). Venous blood samples were collected at rest for the determination of sex hormones, cortisol, CRP, peripheral blood mononuclear memory and naïve CD4+ T-cells, CD8+ T-cells and natural killer cells, as well as pro- and anti-inflammatory cytokine concentrations. C-reactive protein concentrations were elevated (p < 0.001) in AthletesOC (median = 2.02, IQR = 3.15) compared to AthletesNC (median = 0.57, IQR = 1.07). No differences were reported for cortisol, cytokines, or PBMC immune cell subsets, although there was a trend (p = 0.062) for higher IL-6 concentrations in AthletesNC. Female Olympians had substantially higher CRP concentrations, a marker of inflammation and tissue damage, before the Rio Olympic Games if they used an OC. Future research should examine the potential consequences for athlete performance/recovery so that, if necessary, practitioners can implement prevention programs.
|
Statistics for this ePrint Item |
Actions (login required)
 |
Archive Repository Staff Only |